Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer

Figure 3

CERS2 protein staining in clinical bladder cancer tissues. Representative cases of (a) strong staining (high expression), (b) moderate staining (moderate expression), (c) weak staining (low expression), and (d) negative control at 400x magnification. The expression of CERS2 in the tissue samples was evaluated based on the staining intensity. CERS2 protein expression in bladder cancer tissues stratified based on tumour grade (e) and stage (f).

(a)

(b)

(c)

(d)

(e)

(f)